SCHEMBL7500446

SCHEMBL7500446

CC#CCCn1c(=O)ccc2cnc(Nc3ccccc3)nc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 18/20 0.73
CCND1 P24385 18/20 0.73
CCND2 P30279 18/20 0.73
CCND3 P30281 18/20 0.73
CCNB2 O95067 3/20 0.73
CCNE2 O96020 3/20 0.73
CDK1 P06493 3/20 0.73
FGFR1 P11362 3/20 0.73
CCNB1 P14635 3/20 0.73
CCNA2 P20248 3/20 0.73
FGFR2 P21802 3/20 0.73
FGFR4 P22455 3/20 0.73
FGFR3 P22607 3/20 0.73
CCNE1 P24864 3/20 0.73
CDK2 P24941 3/20 0.73
CCNA1 P78396 3/20 0.73
CCNB3 Q8WWL7 3/20 0.73
SRC P12931 1/20 0.69
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266475 0.85 CDK4 (1.00) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL5264561 0.83 CDK4 (1.00) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL5263860 0.82 CDK4 (1.00) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL5264359 0.82 CDK4 (1.00) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL5264829 0.82 CDK4 (0.77) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL7501455 0.82 CDK4 (0.93) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL5264375 0.81 CDK4 (0.76) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL7508840 0.81 CDK4 (0.74) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL5265881 0.80 CDK4 (1.00) CDK4CCND1CCND2CCND3CCNB2
SCHEMBL5264671 0.80 CDK4 (0.87) CDK4CCND1CCND2CCND3CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255755-A1 PYRIDOPYRIMIDINONE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASE WARNER-LAMBERT COMPANY (US) 2002-11-13 EP disclosed
WO-2001055148-A1 PYRIDOPYRIMIDINONE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASE WARNER-LAMBERT COMPANY (US) 2001-08-02 WO disclosed
EP-0964864-A2 PYRIDO 2,3-D] PYRIMIDINES AND 4-AMINOPYRIMIDINES AS INHIBITORS OF CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1999-12-22 EP disclosed
WO-1998033798-A2 PYRIDO[2,3-D]PYRIMIDINES AND 4-AMINO-PYRIMIDINES AS INHIBITORS OF CELL PROLIFERATION WARNER LAMBERT COMPANY (US) 1998-08-06 WO disclosed